IMMUNOCORE HOLDINGS 2.5 02/01/2030 SDBCV is a security (CUSIP 45258DAB1) tracked across SEC portfolio filings. 27 institutional managers reported $337.2M on Form 13F as of 2026-06-30; 4 registered fund positions totaling $16.1M via N-PORT as of 2026-04-30.
Showing 15 of 27 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Linden Advisors LP | New York, NY | $81.9M | 90,836,000 |
| Context Capital Management, LLC | LAJOLLA, CA | $63.7M | 69,292,000 |
| CAMDEN ASSET MANAGEMENT L P /CA | Los Angeles, CA | $38.3M | 42,728,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $27.0M | 30,000,000 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $22.6M | 24,998,000 |
| Kohlberg Kravis Roberts & Co. L.P. | NEW YORK, NY | $18.2M | 20,127,000 |
| FRANKLIN RESOURCES INC | San Mateo, CA | $18.0M | 20,000,000 |
| Davidson Kempner Capital Management LP | New York, NY | $17.9M | 20,000,000 |
| STATE STREET CORP | BOSTON, MA | $7.7M | 8,561,000 |
| WOLVERINE ASSET MANAGEMENT LLC | CHICAGO, IL | $7.2M | 8,000,000 |
| M&G PLC | London, X0 | $6.4M | 7,219,000 |
| Polar Capital Holdings Plc | London, X0 | $5.8M | 6,500,000 |
| BlackRock, Inc. | New York, NY | $5.7M | 6,350,000 |
| ADVENT CAPITAL MANAGEMENT /DE/ | NEW YORK, NY | $5.1M | 5,600,000 |
| Walleye Capital LLC | NEW YORK, NY | $2.8M | 3,000,000 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $13.9M | 12.80% |
| KKR Income Opportunities Fund | KKR Income Opportunities Fund | $1.5M | 29.84% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $666K | 10.05% |
| T. Rowe Price Multi-Strategy Total Return Fund | T. ROWE PRICE MULTI-STRATEGY TOTAL RETURN FUND, INC. | $17K | 0.75% |